About CG Oncology, Inc.
Are you ready to make a difference in the world and become part of our patient-centered team that is focused on Attacking Bladder Cancer for a Better Tomorrow? At CG Oncology, we believe that by having exceptionally talented individuals on our team who share our passion and enjoy working together, we can truly achieve our Vision and Mission to benefit patients around the world.
Every day we are making significant advancements across our multiple pipelines and are growing rapidly to meet the needs of our patients who cannot afford to wait to benefit from our novel immunotherapies. Please review this job posting and our Values and if they resonate with you and are what you expect from your organization and team, then we would like to hear from you.
About the role
At CG Oncology, clinical data drives critical decisions that shape how new oncology therapies are developed. In this role, you’ll work hands-on with real clinical trial data—building datasets, analyses, and reports that directly support study execution and internal decision-making.
This opportunity is ideal for an early-career clinical data professional who wants to grow technical depth in clinical programming while learning how high-quality data enables successful clinical development in a regulated biotech environment.
Location: Remote
Essential Functions
- Over your first year, you’ll progressively take ownership of core clinical data deliverables, including:
- Build and deliver validated clinical analysis datasets (SDTM, ADaM) from raw data in compliance with CDISC, GxP, and ICH standards.
- Develop and maintain SAS and SQL programs to generate datasets, tables, listings, figures, and recurring reports that withstand validation and review.
- Support fit-for-purpose clinical analyses used in internal data reviews and decision-making.
- Create dashboards and visualizations that help teams track study progress, data quality, and key metrics.
- Collaborate cross-functionally with Clinical Operations, Data Management, Biostatistics, and Clinical Science to clarify requirements and deliver accurate, timely outputs.
- Grow technical independence by writing clean, maintainable code, troubleshooting issues, and improving processes over time.
You’re successful in this role if:
- Your datasets and outputs consistently pass review with minimal rework
- Your code is clear, well-documented, and reusable
- You proactively identify data issues and help resolve them
- You steadily increase ownership and confidence in your programming and analysis work
- Stakeholders trust the accuracy and clarity of the data you deliver
Qualifications
- Have 1–2+ years of experience in biotech, pharma, or a CRO
- Enjoy working with clinical trial data and care deeply about data quality
- Have hands-on experience or training in SAS, SQL, and CDISC standards (SDTM, ADaM)
- Are curious, detail-oriented, and eager to learn in a regulated environment
- Communicate clearly and collaborate well with cross-functional partners
Education: Bachelor’s or Master’s degree in Statistics, Data Science, Computer Science, Bioinformatics, or a related field (or equivalent experience).
We hire for long-term success. This role is designed to be a true growth opportunity, where your development and CG Oncology’s clinical goals advance together.
Please note that CG Oncology does not accept unsolicited information and/or resumes from search firms or agencies for our job postings. Any resumes or client information submitted to our careers page or any employee of CG Oncology by any search firm or agency without an applicable contract in place will become the property of CG Oncology and no fee(s) will be paid.
Total Rewards
CG Oncology offers very competitive and comprehensive Total Rewards, helping to support and reward our global team of high-performing employees focused on developing bladder-saving therapeutics for patients afflicted with bladder cancer.
- HIGHLY COMPETITIVE SALARIES
- ANNUAL PERFORMANCE/MERIT REVIEWS
- ANNUAL PERFORMANCE BONUSES
- EQUITY
- SPECIAL RECOGNITION
Well-Being Benefits
In addition to our Total Rewards, CG Oncology offers a variety of Well-Being Benefits to meet the majority of the needs of our unique and growing workforce. These benefits are designed to support our team to achieve a healthy balance between work and their personal lives to remain refreshed, engaged, and creating an environment where each person can find a deeper meaning and purpose in their work.
Well-Being Benefits eligibility begins the 1st of the month after hire. While a majority of these benefits are for our US-based workforce, we continue to assess comparable levels of benefits for our international team members that are aligned with country-specific regulations and their national programs offered.
- FULLY REMOTE WORK ENVIRONMENT
- REST AND RECHARGE BENEFITS - Unlimited Flexible Time Off
- HOLIDAYS –In 2025 we will observe 14 holidays
- RETIREMENT – 401K with 100% company Safe Harbor match up to 4% of base salary
- HEALTH (MEDICAL, DENTAL, VISION) – PPO & HDHP – Cigna/Principal
- HEALTH SPENDING ACCOUNTS - HSA (with Annual Company Contribution), FSA, FSA-DC
- ILLNESS & DISABILITY PROTECTION – Company Paid LTD Coverage + Voluntary Plans
- LIFE INSURANCE – Company Paid 1 x base salary + Voluntary Plans
- ADDITIONAL EXCLUSIVE BENEFITS – Voluntary Legal, Pet, Plus More
CG Oncology is an Equal Opportunity Employer:
All applicants will be considered for employment without attention to race, color, religion, sex, sexual orientation, gender identity, national origin, veteran or disability status. At CG Oncology, we are building a community of intelligent and passionate team members that share our Vision, Mission and Values, and while the biotechnology space can feel limited in BIPOC, non-binary and even female representation, we endeavor to make hiring decisions that will continue to grow and support our team in the direction of maintaining cultural diversity and sustainability.
Top Skills
What We Do
CG Oncology, Inc. (Nasdaq: CGON), is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. We see a world where urologic cancer patients can benefit from our innovative oncolytic immunotherapies to live with dignity and have an enhanced quality of life.
Our lead candidate, cretostimogene grenadenorepvec, is an intravesically delivered oncolytic immunotherapy agent in a Phase 3 trial for the treatment of BCG-unresponsive non-muscle invasive bladder cancer. Cretostimogene grenadenorepvec is also in a Phase 2 study in combination with KEYTRUDA® (pembrolizumab) in the same indication. Other types of bladder cancer are being evaluated with cretostimogene grenadenorepvec in combination with OPDIVO® (nivolumab).









